Catalys Pacific, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0002011385

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 2 positions · Total reported value $209.74M · Top-10 concentration 100.0% · Updated 2026-10-30

Last updated: 2026-10-30 · Source: SEC EDGAR Form 13F-HR

Turnover: 50.0% · 0 new · 1 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2026 13F filing, Catalys Pacific, LLC disclosed 2 equity positions with a combined reported value of $209.74M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were MLYS ($196.00M), PHAT ($13.74M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, Catalys Pacific, LLC opened 0 new positions, trimmed 1 and fully exited 0, a turnover rate of 50.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest Catalys Pacific, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Catalys Pacific, LLC is an SEC-registered 13F filer. As of Q3 2026 it reported 2 US equity positions with a combined value of $209.74M. HoldingsHub carries 12 quarters of its filings (Q4 2023–Q3 2026).

Portfolio Structure

  • 2 positions · $209.74M reported value (Q3 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: MLYS (Mineralys Therapeutics, Inc.) at 93.4%
  • Average position size: $104.87M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 1 added, 1 reduced

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The Catalys Pacific, LLC fund seems to have adopted a cautious approach, focusing on trimming its position in Mineralys Therapeutics Inc. while significantly increasing its stake in Phathom Pharmaceuticals Inc. This indicates a preference for growth in the health care sector with an eye toward emerging companies. 2. Key Moves: - Reduce: Mineralys Therapeutics Inc. (MLYS) was trimmed by 1.3% quarterly, with 105,320 shares sold, totaling $7,799,518 in value. - Add: Phathom Pharmaceuticals Inc. (PHAT) saw a 26.0% increase quarterly, with 388,185 shares added, totaling $1,882,039 in value. 3. Portfolio Structure: - The portfolio seems to have an active management approach, as the fund made significant changes to its holdings. - There is a sector bias towards health care, which is a high-growth and innovation-driven sector. - The risk appetite is not clear, but the increase in a biotech company (Phathom Pharmaceuticals) suggests a willingness to take on some risk for potential high returns. 4. Per-Holding One-Liner: - MLYS: MINERALYS THERAPEUTICS INC – Biotechnology company focusing on drug development; unverified - PHAT: PHATHOM PHARMACEUTICALS INC – Biotechnology company focusing on developing therapies for central nervous system disorders; unverified 5. One-Sentence Style Summary: The fund Catalys Pacific, LLC is cautiously rebalancing its portfolio by trimming exposure to a health care company and adding to a biotech firm, signaling a shift towards potential high-growth opportunities within the sector.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 7.80M $196.00M 93.45%
93.45%
Reduce
2 1.88M $13.74M 6.55%
6.55%
Add

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 100% R 100% F1 100% (modelled on 2026-Q2; 2/10 hit)

Historical Backtest (10 quarters)

Avg precision 97% · recall 100% · F1 98% · avg rank error 0.3 · Top-10 turnover 3%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q2 100% 100% 100% MLYS · HLVX · PHAT MLYS · HLVX · PHAT
2024-Q3 100% 100% 100% MLYS · HLVX · PHAT MLYS · PHAT · HLVX
2024-Q4 67% 100% 80% MLYS · PHAT · HLVX MLYS · PHAT
2025-Q1 100% 100% 100% MLYS · PHAT MLYS · PHAT
2025-Q2 100% 100% 100% MLYS · PHAT MLYS · PHAT
2025-Q3 100% 100% 100% MLYS · PHAT MLYS · PHAT
2025-Q4 100% 100% 100% MLYS · PHAT MLYS · PHAT
2026-Q1 100% 100% 100% MLYS · PHAT MLYS · PHAT
2026-Q2 100% 100% 100% MLYS · PHAT MLYS · PHAT
2026-Q3 ★ 100% 100% 100% MLYS · PHAT MLYS · PHAT

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did Catalys Pacific, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Catalys Pacific, LLC reported 2 equity positions worth $209.74M in aggregate; its largest disclosed positions were MLYS ($196.00M), PHAT ($13.74M).

How large is Catalys Pacific, LLC's portfolio?

Catalys Pacific, LLC reported $209.74M of long equity holdings across 2 positions as of 2026-Q3. Top-10 holdings account for 100.0% of reported value.

What is Catalys Pacific, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/catalys-pacific/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →